Our friend Chris Temple from The National Investor just released a special report on Theralase. Below is a brief summary and a link to download the full report. Also consider browsing around Chirs’s site and signing up for the special he is running for his newsletter.
…
Shares of my latest featured opportunity, Canadian-based biotech company Theralase Technologies, have continued to grind back higher toward their 52-week peak.
Interest perked up again this past week when the company announced that its lead cancer-destroying drug had met critical new milestones on the way to the company starting a Phase 1b trial in patients who have Non-Muscle Invasive Bladder Cancer (NMIBC). This division of the company, as I write in my FREE REPORT on Theralase, is where the most explosive investment potential exists.
(NOTE: For a fresh update on Theralase, the company’s C.E.O. Roger White was interviewed just yesterday on the Korelin Economics Report; you can listen to the audio RIGHT HERE.)
As you may know, I do not focus on any one sector in looking for opportunities for my Members (NOTE: I have already recommended that they buy shares of Theralase.) I look for opportunities where they exist, regardless of the industry or sector. And especially with the overall stock market at a level that isn’t exactly cheap, I am especially stressing that we look for opportunities in well-valued individual companies as well as emerging companies with a compelling story!
So, as you can read in my FREE REPORT on Theralase, it has great potential in its protocol to not only treat cancer, but kill cancer cells for good. To boot, it has a division that manufactures and sells an advanced therapeutic laser product; the company has been prominently featured as a godsend by one particular Major League Baseball team, which has used its product to help heal injured players more quickly.
Once you check out this report, I invite you to write back to me with any questions or comments you have on this company, and this compelling investment opportunity. (NOTE: If the above hyper links do not work in your e-mail, simply go to my web site —http://nationalinvestor.com/ — and click on the heading “Featured Opportunities.”)
In fact, do yourself — and your portfolio — a favor. . .and go there now!
Chris Temple — Editor/Publisher
The National Investor
You can get information anywhere. Here, you get knowledge.